These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 4924778)

  • 1. Studies of alpha-methyl-para-tyrosine, L-dopa, and L-tryptophan in depression and mania.
    Bunney WE; Brodie HK; Murphy DL; Goodwin FK
    Am J Psychiatry; 1971 Jan; 127(7):872-81. PubMed ID: 4924778
    [No Abstract]   [Full Text] [Related]  

  • 2. Catecholamines and mania: the effect of alpha-methyl-para-tyrosine on manic behavior and catecholamine metabolism.
    Brodie HK; Murphy DL; Goodwin FK; Bunney WE
    Clin Pharmacol Ther; 1971; 12(2):218-24. PubMed ID: 5554938
    [No Abstract]   [Full Text] [Related]  

  • 3. L-dopa, dopamine, and hypomania.
    Murphy DL; Goodwin FK; Brodie HK; Bunney WE
    Am J Psychiatry; 1973 Jan; 130(1):79-82. PubMed ID: 4682751
    [No Abstract]   [Full Text] [Related]  

  • 4. Estimation of brain amine metabolism in affective illness: cerebrospinal fluid studies utilizing probenecid.
    Post RM; Goodwin FK
    Psychother Psychosom; 1974; 23(1-6):142-58. PubMed ID: 4278087
    [No Abstract]   [Full Text] [Related]  

  • 5. Psychobiological and pharmacological studies of manic-depressive illness.
    Bunney WE; Gershon ES; Murphy DL; Goodwin FK
    J Psychiatr Res; 1972 Sep; 9(3):207-26. PubMed ID: 5083175
    [No Abstract]   [Full Text] [Related]  

  • 6. Regular induction of hypomania by L-dopa in "bipolar" manic-depressive patients.
    Murphy DL; Brodie HK; Goodwin FK; Bunney WE
    Nature; 1971 Jan; 229(5280):135-6. PubMed ID: 4321339
    [No Abstract]   [Full Text] [Related]  

  • 7. L-DOPA, catecholamines, and behavior: a clinical and biochemical study in depressed patients.
    Goodwin FK; Murphy DL; Brodie HK; Bunney WE
    Biol Psychiatry; 1970 Oct; 2(4):341-66. PubMed ID: 4920729
    [No Abstract]   [Full Text] [Related]  

  • 8. Influence of affective states and psychoactive drugs on verbal learning and memory.
    Henry GM; Weingartner H; Murphy DL
    Am J Psychiatry; 1973 Sep; 130(9):966-71. PubMed ID: 4727774
    [No Abstract]   [Full Text] [Related]  

  • 9. L-tryptophan in mania. Contribution to a permissive hypothesis of affective disorders.
    Prange AJ; Wilson IC; Lynn CW; Alltop LB; Stikeleather RA
    Arch Gen Psychiatry; 1974 Jan; 30(1):56-62. PubMed ID: 4587067
    [No Abstract]   [Full Text] [Related]  

  • 10. Affective disorder: studies with amine precursors.
    Dunner DL; Fieve RR
    Am J Psychiatry; 1975 Feb; 132(2):180-3. PubMed ID: 1089363
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The "switch process" in manic-depressive illness. II. Relationship to catecholamines, REM sleep, and drugs.
    Bunney WE; Goodwin FK; Murphy DL; House KM; Gordon EK
    Arch Gen Psychiatry; 1972 Sep; 27(3):304-9. PubMed ID: 4340658
    [No Abstract]   [Full Text] [Related]  

  • 12. L-dopa, behavioral activation and psychopathology.
    Murphy DL
    Res Publ Assoc Res Nerv Ment Dis; 1972; 50():472-93. PubMed ID: 4627219
    [No Abstract]   [Full Text] [Related]  

  • 13. A controlled trial of L-tryptophan in mania.
    Chambers CA; Naylor GJ
    Br J Psychiatry; 1978 Jun; 132():555-9. PubMed ID: 350328
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and pharmacological investigations of the psychobiology of the affective disorders.
    Murphy DL; Goodwin FK; Bunney WE
    Int Pharmacopsychiatry; 1971; 6(3):137-46. PubMed ID: 4150691
    [No Abstract]   [Full Text] [Related]  

  • 15. Alternative catecholamine pathways after tyrosine hydroxylase inhibition in malignant pheochromocytoma.
    Kuchel O; Buu NT; Edwards DJ
    J Lab Clin Med; 1990 Apr; 115(4):449-53. PubMed ID: 1969915
    [TBL] [Abstract][Full Text] [Related]  

  • 16. L-tryptophan in depression.
    Farkas T; Dunner DL; Fieve RR
    Biol Psychiatry; 1976 Jun; 11(3):295-302. PubMed ID: 779855
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cerebral and peripheral L-dopa uptake in patients with parkinsonian, depressive or manic syndromes administered L-dopa by perfusion combined or not with a decarboxylase inhibitor. Pharmacological effects].
    Geissbuhler F; Eisenring JJ; Friedli P; Bartholini G; Tissot R
    Encephale; 1972; 61(2):127-48. PubMed ID: 4634903
    [No Abstract]   [Full Text] [Related]  

  • 18. Presynaptic catecholamine antagonists as treatment for Tourette syndrome. Effects of alpha methyl para tyrosine and tetrabenazine.
    Sweet RD; Bruun R; Shapiro E; Shapiro AK
    Arch Gen Psychiatry; 1974 Dec; 31(6):857-61. PubMed ID: 4613321
    [No Abstract]   [Full Text] [Related]  

  • 19. Cyclic AMP in cerebrospinal fluid of manic and depressive patients.
    Post RM; Cramer H; Goodwin FK
    Psychol Med; 1977 Nov; 7(4):599-605. PubMed ID: 201957
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of L-DOPA on depression.
    Bunney WE; Janowsky DS; Goodwin FK; Davis JM; Brodie HK; Murphy DL; Chase TN
    Lancet; 1969 Apr; 1(7600):885-6. PubMed ID: 4180540
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.